CN1354747A - 治疗肥胖症的2-氨基-4h-3,1-苯并噁嗪-4-酮衍生物 - Google Patents
治疗肥胖症的2-氨基-4h-3,1-苯并噁嗪-4-酮衍生物 Download PDFInfo
- Publication number
- CN1354747A CN1354747A CN00803621A CN00803621A CN1354747A CN 1354747 A CN1354747 A CN 1354747A CN 00803621 A CN00803621 A CN 00803621A CN 00803621 A CN00803621 A CN 00803621A CN 1354747 A CN1354747 A CN 1354747A
- Authority
- CN
- China
- Prior art keywords
- ketone
- benzoxazine
- alkyl
- amino
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
Abstract
Description
化合物号数 | 原料1 | 原料2 |
2 | 2-氨基苯甲酸 | 4-丁基苯基异氰酸酯 |
8 | 2-氨基苯甲酸 | 4-苯氧基苯基异氰酸酯 |
10 | 2-氨基苯甲酸 | 4-(1-甲基乙基)苯基异氰酸酯 |
11 | 2-氨基苯甲酸 | 4-三氟甲基苯基异氰酸酯 |
12 | 2-氨基苯甲酸 | 3-三氟甲基苯基异氰酸酯 |
13 | 2-氨基-5-甲基苯甲酸 | 1-萘基异氰酸酯 |
14 | 2-氨基-5-甲基苯甲酸 | 4-丁氧基羰基苯基异氰酸酯 |
15 | 2-氨基-5-甲基苯甲酸 | 4-苯氧基苯基异氰酸酯 |
17 | 2-氨基-4-氟苯甲酸 | 异氰酸苯酯 |
18 | 2-氨基-6-氟苯甲酸 | 异氰酸苯酯 |
19 | 2-氨基-4-甲基苯甲酸 | 异氰酸苯酯 |
20 | 2-氨基-4-乙基苯甲酸 | 异氰酸苯酯 |
21 | 2-氨基-5-甲基苯甲酸 | 4-己基苯基异氰酸酯 |
22 | 2-氨基-5-甲基苯甲酸 | 4-庚氧基苯基异氰酸酯 |
23 | 2-氨基-4-辛基苯甲酸 | 异氰酸苯酯 |
24 | 2-氨基-4-甲基苯甲酸 | 4-苯氧基苯基异氰酸酯 |
25 | 2-氨基-5-甲基苯甲酸 | 异氰酸十六烷基酯 |
26 | 2-氨基-4-丁基苯甲酸 | 异氰酸苯酯 |
27 | 2-氨基-4-甲基苯甲酸 | 2-苯氧基苯基异氰酸酯 |
28 | 2-氨基-4-甲基苯甲酸 | 3-苯氧基苯基异氰酸酯 |
29 | 2-氨基-4-甲基苯甲酸 | 4-苯甲酰苯基异氰酸酯 |
30 | 2-氨基-4-三氟甲基苯甲酸 | 4-苯氧基苯基异氰酸酯 |
31 | 2-氨基-4-甲基苯甲酸 | 4-辛基苯基异氰酸酯 |
32 | 3-氨基吡啶-4-羧酸 | 异氰酸苯酯 |
33 | 2-氨基-4-甲基苯甲酸 | 异氰酸氰基苯酯 |
Claims (32)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900416.0 | 1999-01-08 | ||
GBGB9900416.0A GB9900416D0 (en) | 1999-01-08 | 1999-01-08 | Inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1354747A true CN1354747A (zh) | 2002-06-19 |
CN100480245C CN100480245C (zh) | 2009-04-22 |
Family
ID=10845777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008036217A Expired - Fee Related CN100480245C (zh) | 1999-01-08 | 2000-01-06 | 治疗肥胖症的2-氨基-4h-3,1-苯并嗪-4-酮衍生物 |
Country Status (22)
Country | Link |
---|---|
US (2) | US6656934B2 (zh) |
EP (1) | EP1144395B1 (zh) |
JP (1) | JP2002534419A (zh) |
KR (1) | KR100615914B1 (zh) |
CN (1) | CN100480245C (zh) |
AR (1) | AR022203A1 (zh) |
AT (1) | ATE293610T1 (zh) |
AU (1) | AU770342B2 (zh) |
CA (1) | CA2359987C (zh) |
DE (1) | DE60019556T2 (zh) |
DK (1) | DK1144395T3 (zh) |
ES (1) | ES2240051T3 (zh) |
GB (1) | GB9900416D0 (zh) |
HK (1) | HK1047284A1 (zh) |
HU (1) | HUP0104909A3 (zh) |
MY (1) | MY129247A (zh) |
NO (1) | NO321058B1 (zh) |
NZ (1) | NZ512739A (zh) |
PL (1) | PL350412A1 (zh) |
PT (1) | PT1144395E (zh) |
RU (1) | RU2244711C2 (zh) |
WO (1) | WO2000040569A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103403001A (zh) * | 2011-01-13 | 2013-11-20 | 诺瓦提斯公司 | 新的杂环衍生物及其在神经性疾病治疗中的应用 |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9900416D0 (en) * | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
CA2286451A1 (en) * | 1999-10-14 | 2001-04-14 | Grant A. Mitchell | Hormone-sensitive lipase mediated male infertility |
GB0001572D0 (en) * | 2000-01-24 | 2000-03-15 | Alizyme Therapeutics Ltd | Inhibitors |
HU229550B1 (en) | 2000-06-27 | 2014-01-28 | Hoffmann La Roche | Method for preparing compositions |
CA2416900C (en) | 2000-07-28 | 2007-07-03 | F. Hoffmann-La Roche Ag | The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels |
RS50397B (sr) | 2000-07-28 | 2009-12-31 | F. Hoffmann-La Roche Ag., | Farmaceutska smeša |
US20030027786A1 (en) | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
US6730319B2 (en) | 2001-06-06 | 2004-05-04 | Hoffmann-La Roche Inc. | Pharmaceutical compositions having depressed melting points |
DE10135027A1 (de) * | 2001-07-18 | 2003-02-06 | Solvay Pharm Gmbh | Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen |
JP2005508619A (ja) | 2001-08-03 | 2005-04-07 | ディヴァーサ コーポレイション | エポキシドヒドロラーゼ、それらをコードした核酸及びそれらの作製法と利用法 |
US6943001B2 (en) | 2001-08-03 | 2005-09-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
HUP0401318A3 (en) | 2001-08-22 | 2008-03-28 | Sanofi Aventis Deutschland | Combined preparations containing 2,3,4,5-tetrahydro-benzo[b]thiepine-1,1-dioxide derivatives and other active substances, and the use thereof |
PL368994A1 (en) | 2001-08-30 | 2005-04-04 | Alizyme Therapeutics Limited | Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
US6884812B2 (en) | 2001-08-31 | 2005-04-26 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals |
RS50889B (sr) | 2001-08-31 | 2010-08-31 | Sanofi-Aventis Deutschland Gmbh. | Derivati diaril-cikloalkila, postupak za njihovu proizvodnju i njihova primena u svojstvu ppar aktivatora |
US7399777B2 (en) | 2001-08-31 | 2008-07-15 | Sanofi-Aventis Deutschland Gmbh | Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals |
EP1467978A4 (en) * | 2001-12-20 | 2005-11-02 | Osi Pharm Inc | "COMPOUNDS THAT CONTAIN VACCINATES DRUG LIPASE, THEIR SYNTHESIS AND USE" |
US7078404B2 (en) | 2002-04-11 | 2006-07-18 | Sanofi-Aventis Deutschland Gmbh | Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use |
US7223796B2 (en) | 2002-04-11 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
US7049341B2 (en) | 2002-06-07 | 2006-05-23 | Aventis Pharma Deutschland Gmbh | N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use |
DE10231370B4 (de) | 2002-07-11 | 2006-04-06 | Sanofi-Aventis Deutschland Gmbh | Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
US7262220B2 (en) | 2002-07-11 | 2007-08-28 | Sanofi-Aventis Deutschland Gmbh | Urea- and urethane-substituted acylureas, process for their preparation and their use |
JP2006502247A (ja) | 2002-07-12 | 2006-01-19 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 複素環で置換されたベンゾイル尿素、その製造方法および医薬としてのその使用 |
US20040157922A1 (en) | 2002-10-04 | 2004-08-12 | Aventis Pharma Deutschland Gmbh | Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments |
US7208504B2 (en) | 2002-10-12 | 2007-04-24 | Sanofi-Aventis Deutschland Gmbh | Bicyclic inhibitors of hormone sensitive lipase |
DE10258007B4 (de) | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
US8372430B2 (en) | 2002-12-17 | 2013-02-12 | The Procter & Gamble Company | Compositions, methods, and kits useful for the alleviation of gastrointestinal effects |
US20040242583A1 (en) | 2003-01-20 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use |
US7179941B2 (en) | 2003-01-23 | 2007-02-20 | Sanofi-Aventis Deutschland Gmbh | Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
DE10306250A1 (de) | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US7196114B2 (en) | 2003-02-17 | 2007-03-27 | Sanofi-Aventis Deutschland Gmbh | Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
DE10308353A1 (de) | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
DE10308352A1 (de) | 2003-02-27 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
DE10308351A1 (de) | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
US7501440B2 (en) | 2003-03-07 | 2009-03-10 | Sanofi-Aventis Deutschland Gmbh | Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use |
DE10314610A1 (de) | 2003-04-01 | 2004-11-04 | Aventis Pharma Deutschland Gmbh | Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung |
EP1631272A4 (en) * | 2003-06-12 | 2009-01-07 | Menachem Rubinstein | METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS USING TELLURE AND SELENIUM-CONTAINING COMPOUNDS |
US7008957B2 (en) | 2003-07-25 | 2006-03-07 | Sanofi-Aventis Deutschland Gmbh | Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments |
US7094800B2 (en) | 2003-07-25 | 2006-08-22 | Sanofi-Aventis Deutschland Gmbh | Cyanopyrrolidides, process for their preparation and their use as medicaments |
US7094794B2 (en) | 2003-07-28 | 2006-08-22 | Sanofi-Aventis Deutschland Gmbh | Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
DE10335092B3 (de) | 2003-08-01 | 2005-02-03 | Aventis Pharma Deutschland Gmbh | Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung |
US7241787B2 (en) | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
US7402674B2 (en) | 2004-01-31 | 2008-07-22 | Sanofi-Aventis Deutschland Gmbh, | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
US7498341B2 (en) | 2004-01-31 | 2009-03-03 | Sanofi Aventis Deutschland Gmbh | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
US7470706B2 (en) | 2004-01-31 | 2008-12-30 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
DE102004005172A1 (de) | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
EP1586573B1 (en) | 2004-04-01 | 2007-02-07 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
RU2007119315A (ru) | 2004-10-25 | 2008-11-27 | Зольвай Фармасьютиклз Гмбх (De) | Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний |
DE102004059470A1 (de) * | 2004-12-10 | 2006-06-14 | Lanxess Deutschland Gmbh | Verfahren zur Herstellung von Carbaminsäureester-Derivaten |
US20090082435A1 (en) * | 2005-04-28 | 2009-03-26 | The Regents Of The University Of California | Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
DE102005026762A1 (de) | 2005-06-09 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
EP1951688A1 (en) * | 2005-10-25 | 2008-08-06 | Council of Scientific and Industrial Research | A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
PL2383271T3 (pl) | 2006-03-13 | 2013-12-31 | Kyorin Seiyaku Kk | Aminochinolony jako inhibitory GSK-3 |
DE102006028862A1 (de) | 2006-06-23 | 2007-12-27 | Merck Patent Gmbh | 3-Amino-imidazo[1,2-a]pyridinderivate |
RU2009108280A (ru) | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
US20100179131A1 (en) | 2006-09-07 | 2010-07-15 | Nycomed Gmbh | Combination treatment for diabetes mellitus |
DE102007002260A1 (de) | 2007-01-16 | 2008-07-31 | Sanofi-Aventis | Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
DE102007008420A1 (de) | 2007-02-21 | 2008-08-28 | Merck Patent Gmbh | Benzimidazolderivate |
PT2152663E (pt) | 2007-06-04 | 2014-06-03 | Univ Ben Gurion | Compostos de triarilo e composições que compreendem os mesmos |
AU2008299903B2 (en) | 2007-09-11 | 2013-08-29 | Kyorin Pharmaceutical Co., Ltd | Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
CN101855229A (zh) | 2007-09-12 | 2010-10-06 | 埃迪威克斯生物科学公司 | 作为gsk-3抑制剂的螺环状氨基喹诺酮 |
DE102007048716A1 (de) | 2007-10-11 | 2009-04-23 | Merck Patent Gmbh | Imidazo[1,2-a]pyrimidinderivate |
DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
DE102008017590A1 (de) | 2008-04-07 | 2009-10-08 | Merck Patent Gmbh | Glucopyranosidderivate |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
JP2010254623A (ja) * | 2009-04-24 | 2010-11-11 | Takeda Chem Ind Ltd | ベンゾオキサジノン化合物の結晶 |
WO2011023754A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi-Aventis | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
AU2010302642A1 (en) | 2009-10-02 | 2012-04-26 | Sanofi | Use of compounds with SGLT-1/SGLT-2 inhibitor activity for producing medicaments for treatment of bone diseases |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP6657101B2 (ja) | 2013-11-05 | 2020-03-04 | ベン グリオン ユニバーシティ オブ ザ ネガフ リサーチ アンド ディベロップメント オーソリティ | 糖尿病及びそれから生じる疾患合併症の治療のための化合物 |
CN104374836A (zh) * | 2014-09-19 | 2015-02-25 | 安徽安科生物工程(集团)股份有限公司 | 西替利司他及有关杂质的hplc测定方法 |
CN105622539B (zh) * | 2016-03-11 | 2016-11-23 | 中山万汉医药科技有限公司 | 一种西替利司他的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3450700A (en) * | 1966-12-20 | 1969-06-17 | Upjohn Co | 2-tertiary amino-4h-3,1-benzoxazin-4-ones |
DE2315303A1 (de) * | 1973-03-27 | 1974-10-17 | Bayer Ag | Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen |
NZ210669A (en) * | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
US4657893A (en) * | 1984-05-09 | 1987-04-14 | Syntex (U.S.A.) Inc. | 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors |
US4665070A (en) | 1985-06-25 | 1987-05-12 | Syntex (U.S.A.) Inc. | 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use |
US4745116A (en) | 1985-06-25 | 1988-05-17 | Syntex (U.S.A.) Inc. | 2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
US5985872A (en) * | 1995-05-24 | 1999-11-16 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
US5776756A (en) * | 1995-08-31 | 1998-07-07 | Toyo Hakko Co., Ltd. | Fermentation compositions having superoxide dismutating activity and an antihypertensive agent for treatment of constipation each having the superoxide dismutating activity |
GB9900416D0 (en) * | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
-
1999
- 1999-01-08 GB GBGB9900416.0A patent/GB9900416D0/en not_active Ceased
-
2000
- 2000-01-05 AR ARP000100028A patent/AR022203A1/es active IP Right Grant
- 2000-01-06 ES ES00900081T patent/ES2240051T3/es not_active Expired - Lifetime
- 2000-01-06 NZ NZ512739A patent/NZ512739A/en not_active IP Right Cessation
- 2000-01-06 EP EP00900081A patent/EP1144395B1/en not_active Expired - Lifetime
- 2000-01-06 CN CNB008036217A patent/CN100480245C/zh not_active Expired - Fee Related
- 2000-01-06 AU AU18845/00A patent/AU770342B2/en not_active Ceased
- 2000-01-06 KR KR1020017008596A patent/KR100615914B1/ko not_active IP Right Cessation
- 2000-01-06 MY MYPI20000045A patent/MY129247A/en unknown
- 2000-01-06 PT PT00900081T patent/PT1144395E/pt unknown
- 2000-01-06 DK DK00900081T patent/DK1144395T3/da active
- 2000-01-06 AT AT00900081T patent/ATE293610T1/de not_active IP Right Cessation
- 2000-01-06 CA CA002359987A patent/CA2359987C/en not_active Expired - Fee Related
- 2000-01-06 WO PCT/GB2000/000031 patent/WO2000040569A1/en active Search and Examination
- 2000-01-06 PL PL00350412A patent/PL350412A1/xx not_active Application Discontinuation
- 2000-01-06 RU RU2001121983/04A patent/RU2244711C2/ru not_active IP Right Cessation
- 2000-01-06 HU HU0104909A patent/HUP0104909A3/hu unknown
- 2000-01-06 JP JP2000592277A patent/JP2002534419A/ja not_active Withdrawn
- 2000-01-06 DE DE60019556T patent/DE60019556T2/de not_active Expired - Lifetime
-
2001
- 2001-07-06 NO NO20013380A patent/NO321058B1/no not_active IP Right Cessation
- 2001-07-06 US US09/901,868 patent/US6656934B2/en not_active Expired - Fee Related
-
2002
- 2002-11-27 US US10/306,375 patent/US7776853B2/en not_active Expired - Fee Related
- 2002-12-12 HK HK02109007.0A patent/HK1047284A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103403001A (zh) * | 2011-01-13 | 2013-11-20 | 诺瓦提斯公司 | 新的杂环衍生物及其在神经性疾病治疗中的应用 |
CN103403001B (zh) * | 2011-01-13 | 2016-08-17 | 诺瓦提斯公司 | 杂环衍生物及其在神经性疾病治疗中的应用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1354747A (zh) | 治疗肥胖症的2-氨基-4h-3,1-苯并噁嗪-4-酮衍生物 | |
CN1915981A (zh) | 治疗肥胖症的2-氧-4h-3,1-苯并噁嗪-4-酮 | |
CN1889960A (zh) | 用于功能上影响不同类型的细胞和用于治疗免疫、炎症、神经和其他疾病的新的二肽基肽酶iv抑制剂 | |
CN1423640A (zh) | 在8a位被取代的8,8a-二氢茚并[1,2-d]噻唑衍生物、它们的制备方法和它们作为药物、例如减食欲剂的用途 | |
CN1711249A (zh) | 可用作抗痛觉过敏剂的喹唑啉酮衍生物 | |
CN1294578A (zh) | 新的萘基和酰苯胺取代的磺酰胺 | |
CN1166623C (zh) | 2-苯氧基苯胺类衍生物 | |
CN1319096A (zh) | 喹唑啉衍生物及其药物用途 | |
EP1255742B1 (en) | 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors | |
CN1556706A (zh) | 具有脂肪酶抑制活性的噻吩并-(1,3)-噁嗪-4-酮 | |
CN1199957C (zh) | 塞曲司特衍生物及其制备方法与抗哮喘活性 | |
CN1193012A (zh) | 氨磺酰取代的化合物、其制备方法、它们作为药物或诊断剂的用途以及含有它们的药物 | |
TWI293953B (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1047284 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: ROGENY CO., LTD. Free format text: FORMER OWNER: ALICIMO THERAPEUTICS CO., LTD. Effective date: 20091218 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091218 Address after: Amsterdam Patentee after: Alizyme Therapeutics Ltd. Address before: cambridge Patentee before: Alizyme Therapeutics Ltd. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090422 Termination date: 20110106 |